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VP1, the putative virion-associated RNA-dependent RNA polymerase (RdRp) of infectious pancreatic necrosis virus (IPNV) can be
guanylylated in vitro whereupon it becomes a primer for in vitro RNA synthesis [Virology 208 (1995) 19]. The role of a template or other
virion polypeptides in the reaction is unknown. To shed light on this question, his-tagged recombinant VP1 (rVP1) was expressed both in
Escherichia coli and insect cells and used in the guanylylation reaction. Unlike other viral VPg polypeptides, the purified rVP1 alone could
guanylylate itself in vitro in a template-independent manner. Chemical and enzymatic cleavage in combination with site-directed mutagenesis
mapped the site of guanylylation to serine 163. The purified rVP1 functioned as a primer as well as an RdRp in vitro, producing labeled
dsRNA in the presence of [a32P] NTP and synthetically produced viral ss + RNA as a template. Only a single cycle of replication was
observed and labeled VPg could be recovered from the dsRNA by RNase V1 digestion. Denaturation of the dsRNA yielded genome-length
labeled ssRNA, indicating that RNA synthesis was not initiated by 3V-end snap-back self-priming. Mutating serine 163 to alanine of rVP1
abolished both its self-guanylylating and polymerizing activity.
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Infectious pancreatic necrosis virus (IPNV) is the proto-
type of the family Birnaviridae. The virion contains a
bisegmented dsRNA genome which is surrounded by a
medium-size (60 nm) unenveloped, single-shelled, icosahe-
dral capsid. Genome segment A (3097 bp) contains two
overlapping reading frames (ORFs): a large ORF encoding a
106-kDa polyprotein (NH2-preVP2-protease-VP3-COOH)
which is co-translationally cleaved by the protease to
generate the major capsid proteins VP2 and VP3 (Duncan
et al., 1987; for review, see Dobos, 1995a); and a second
small ORF which overlaps the amino end of the large ORF
in a different reading frame and encodes a nonstructural 17-
kDa arginine-rich polypeptide (Magyar and Dobos, 1994).
Polypeptide VP2 serves for virus-cell attachment and binds
to neutralizing antibodies (Liao and Dobos, 1995). The
internal VP3 polypeptide is bound to the viral genome0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: pdobos@uoguelph.ca (P. Dobos).(Hjalmarsson et al., 1999) but distinct, spherical core
particles are not found in birnaviruses.
The product of genome segment B (2784 bp) is a minor
internal 94-kDa capsid polypeptide VP1 which, based on
its size, low copy number in virions, and the presence of
several conserved domains associated with RNA-depen-
dent RNA polymerases (RdRp) of other RNA viruses, is
the putative virion-associated RdRp (Duncan et al., 1991;
Shwed et al., 2002). VP1 is present in the virion in two
forms; as a free polypeptide (VP1) and as a genome-linked
protein (VPg) where it is linked to the 5V end of both
genome segments by a serine 5VGMP phosphodiester bond
(Calvert et al., 1991). VP1 is also present as VPg in other
birnaviruses such as infectious bursal disease virus (IBDV)
(Mu¨ller and Nitschke, 1987) and Drosophila X virus
(DXV) (Revet and Delain, 1982). Virion-associated in
vitro RdRp activity has been demonstrated in purified
preparations of all three birnaviruses (DXV: Bernard,
1980; IPNV: Mertens et al., 1982; and IBDV: Spies et
al., 1987).
Guanylylation of VP1 in vitro was demonstrated using
purified IPNV and IBDV (Dobos, 1993) and DXV (Shwed
et al., 2002). During this reaction, both VP1-pG and VP1-
Fig. 1. Purification of recombinant baculovirus-expressed rVP1 by metal
affinity chromatography. (A) Coomassie brilliant blue staining after 10%
SDS-PAGE; (B)Western blotting using anti-IPNV serum. Lane designations:
M, molecular mass standards in kilodaltons are given on the left; U,
uninfected cell lysate; I, infected cell lysate; FT, flow-through; W1, W2, and
W3, washes 1, 2, and 3; EL, eluted sample. The position of rVP1 is indicated
on the right.
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strands of both genome segments of all three viruses end
with pCpC, it was proposed that VP1-pGpG acts as a primer
during initiation of viral RNA synthesis. This theory was
strengthened by the following subsequent experiments: (i)
during in vitro RNA synthesis by the virion-associated
RdRp of IPNV, labeled VP1-GMP could be ‘‘chased’’ via
VP1-GMP(pN)n intermediates of different chain lengths
into replicative intermediates (RIs) and finally to VPg–
dsRNA complexes. The labeled VP1-GMP could be recov-
ered from these complexes by digestion with ribonuclease
V1 (a double-stranded RNase). The results also showed that
during in vitro RNA transcription only plus sense RNA
strands were synthesized and these remained base-paired to
their negative-strand templates (Dobos, 1995b). (ii) Protein-
primed RNA synthesis was also demonstrated in vivo in
IPNV-infected fish cell cultures (Magyar et al., 1998). To
date, birnaviruses are the only dsRNA viruses with a
genome-linked protein and the only dsRNA viruses exhibit-
ing protein-primed RNA synthesis.
In all dsRNA viruses RNA synthesis occurs in large
polymerase complexes which contain the putative poly-
merase. For example, chymotrypsin treatment of reovirus
converts them into cores which are active in in vitro
transcription producing large amounts of mRNA from
each genome segment by a conservative mechanism
(Joklik, 1972); nucleocapsids (NC) obtained from deter-
gent treatment of the enveloped, dsRNA containing phage
B6 also produces mRNA but by a semiconservative
mechanism (Yang et al., 2003). In this respect, IPNV
behaves like the transcriptionally active NC of phage B6
except that reinitiation of transcription is not observed
(Dobos, 1995b).
In vitro synthesis of rotavirus dsRNA on mRNA tem-
plates could be demonstrated by recombinant rotavirus VP1
(RNA polymerase) only when it was combined with recom-
binant VP2 (core lattice protein) (Patton et al., 1997). In the
case of phage B6 purified recombinant protein P2 (the
polymerase subunit of the replicase complex) was shown
in vitro to act as both a replicase and a transcriptase
(Makeyev and Bamford, 2000a, 2000b).
In this communication, we show that recombinant-puri-
fied VP1 of IPNV functions as a replicase. rVP1 can
guanylylate itself in vitro at serine residue 163, and this
VP1pGpG complex in turn serves as a primer for in vitro
RNA synthesis producing viral dsRNA when supplied with
synthetic genome segment A plus strand as template.
Labeled VP1-pG can be released from the dsRNA by RNase
V1 treatment, and heat-denaturation of the dsRNA yields
genome-length ssRNA, indicating that the dsRNA is not the
product of snap-back self-priming by the 3V end of the
template. Serine to alanine mutation of residue 163 abol-
ishes both self-guanylylating and RNA polymerase activity
of the recombinant VP1. We conclude that the RNA
priming and polymerase activities reside in the same
(VP1) polypeptide.Results
Purification of recombinant VP1
Virion VP1 can be guanylylated in vitro, but it is not
known if VP1 can self-guanylylate or if any of the other
virion polypeptides such as VP3 or VP2 or viral RNA are
also necessary as auxiliary macromolecules. To resolve this
question, recombinant VP1 has to be produced, purified,
and used in an in vitro guanylylation reaction. To this end,
the VP1 ORF was fused in frame to a C-terminal His tag
and expressed in both Escherichia coli and in insect cell
cultures (via recombinant baculovirus). To prevent the
intracellular formation of insoluble aggregates of rVP1, it
was important to reduce the incubation temperature to 18–
20 jC after IPTG induction of bacterial cultures or after
infection of SF cell cultures. Purification of the rVP1 in both
cases utilized metal affinity chromatography and as a final
step involved concentration and buffer exchange in 10 mM
Tris–HCl pH 8.0 (which was the buffer used for in vitro
guanylylation), containing 10 mM NaCl and 20% glycerol
to increase the solubility and stability of the protein. This
preparation was stable for months when stored at 20 jC.
The purification steps were monitored by SDS-PAGE and
Western blotting as shown in Fig. 1 which represents rVP1
expression in recBaculovirus-infected SF cells. Similar
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cultures (data not shown). Unless otherwise stated, experi-
ments presented below were performed with rVP1
expressed in insect cells.
Comparison of in vitro guanylylation of virion VP1 vs. rVP1
The parameters of in vitro guanylylation of virion VP1
and rVP1 were compared in the presence of 0.5 mM MgCl2
or 0.5 mM MnCl2 followed by SDS-PAGE, Western blot-
ting, and autoradiography as shown in Fig. 2A. Viral VP1
was labeled equally in the presence of either divalent cation
whereas guanylylation of rVP1 was 4-fold more active
using MnCl2 (Fig. 2B). Pretreatment of rVP1 with RNase
A and DNase (10 Ag/ml, 1 h at room temperature) or
micrococcal nuclease as described by Oh et al. (1999) did
not inhibit the self-guanylylating activity (data not shown),
indicating that cellular RNA or DNA (which may have co-
purified with the rVP1) did not serve as a template for the
reaction. Guanylylation was insensitive to VP1 dilution
indicating self-guanylylation, that is, each VP1 molecule
acts as both the enzyme and the acceptor (data not shown).
Furthermore, no guanylylating activity was observed when
uninfected insect cell lysates were carried through the rVP1
purification procedure (data not shown).
To characterize the radioactive moiety linked to rVP1,
the labeled polypeptide was recovered from polyacrylamideFig. 2. In vitro guanylylation of virion VP1 and rVP1 in the presence of 0.5 mM M
(A) 10% SDS-PAGE and Western blotting; and (B) autoradiography. The position
the rVP1-guanylate linkage. (A) The guanylylation reactions were stopped after
piperidine hydrolysis and thin layer PEI cellulose chromatography followed by aut
marker M (GTP, GDP, GMP, and Pi produced by partial hydrolysis of [a32P]GTP)
analysis of the labeled rVP1–GMP complex. The labeled gel-purified comp
autoradiography as described under Materials and methods. The positions of thegels and incubated with 1 M piperidine and analyzed by PEI
cellulose chromatography followed by autoradiography. As
shown in Fig. 2C, when the guanylylation reaction was
stopped after 1 min and the product hydrolyzed, most of the
radioactivity was released as GMP, whereas after 10 min
both GMP and GDP were released at a ratio of 4:1.
Previously, we have shown using viral VP1 that the two
labeled components represented pG and pGp, respectively;
however, in the case of virions, pGp was the most abundant
form (Dobos, 1993).
To identify the amino acid residue in rVP1 to which
the nucleotide was linked, the labeled polypeptide was
acid hydrolyzed, freeze-dried, and subjected to thin layer
electrophoresis together with phosphoamino acid markers
followed by autoradiography. The result in Fig. 2D
shows that the nucleotide was linked to one of the serine
residues of the polypeptide. Identical results were
obtained previously with virion VP1 (Dobos, 1993). We
conclude from these experiments that purified rVP1 is
capable of self-guanylylation in the absence of other viral
proteins.
Mapping of the location of the serine-GMP linkage;
experimental strategy
Mutating the serine residue involved in the protein-RNA
linkage would result in the loss of self-guanylylating activ-gCl2 or 0.5 mM MnCl2 using [a
32P]GTP. The products were analyzed by
s of the virion polypeptides are indicated on the left. (C) Characterization of
1 and 10 min of incubation at 37 jC. The samples were processed for
oradiography as described under Materials and methods. The location of the
is indicated on the left. Arrow indicates the origin. (D) Phosphoamino acid
lex was subjected to acid hydrolysis, thin layer chromatography, and
origin and the phosphoamino acid markers are indicated on the right.
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Fig. 4. Analysis of single- and double-proteolytic digestion products of
labeled rVP1 by 40% alkaline PAGE and autoradiography. The first and
second digestion is indicated above each lane: V8, trypsin (Tr),
chymotrypsin (Ch).
H.-T. Xu et al. / Virology 322 (2004) 199–210 203ity of the rVP1. Because there are 51 serine residues in VP1,
using chemical and enzymatic cleavage, we have narrowed
down the region of VP1 that had to be analyzed by site-
directed mutagenesis. The methodology and the rationale
are shown in Fig. 3. The linear map of VP1 with the 51
serine residues and three cysteine residues is shown in Fig.
3A. 2-Nitro-5-thiocyanatobenzoic acid (NTCB) chemically
cleaves the polypeptide at the cysteine residues, but because
cleavage is not complete nine possible polypeptides of
different masses are produced (ranging from 5.3 to 61
kDa). The smallest labeled cleavage product will indicate
the approximate location of the labeled serine. Fig. 3AA
shows the polyacrylamide gel analysis of the labeled frag-
ments together with a marker ladder. The smallest labeled
fragment is the 34.2 kDa polypeptide representing the
amino terminal 299 residues of rVP1 which contains 16
serine residues.
N-chlorosuccinimide (NCS) cleaves VP1 at tryptophane
residues resulting in 15 different-sized fragments as shown
in Fig. 3B. The largest fragment at the amino terminus has a
mass of 26 kDa with cleavage at W219 or W223. Fig. 3BB
shows an autoradiogram of a polyacryalamide gel with
labeled NTCB fragments of rVP1 before (lanes 1–4) and
after NCS cleavage (lanes 5–8). The smallest NCS cleavage
product is about 26 kDa. Increasing the amount of NCS
used or extending the time of the cleavage reaction did not
produce additional labeled peptides (data not shown). Thus
the number of possible [a32P]GTP-labeled serines has been
further reduced from 16 to 10.
Proteolytic cleavage of the NCS fragment
The next set of experiments involved the proteolytic
digestion of rVP1. Fig. 3C shows a linear map of the
first 223 residues of VP1 indicating the V8 cleavage
sites; the tryptic cleavage sites are shown in Fig. 3D; and
the chymotryptic cleavage sites in Fig. 3E. The labeled
V8 fragment and the labeled tryptic fragment analyzed in
the same 16% tricine gel are shown in (Fig. 3CC). A
4.2-kDa V8 fragment and a 2-kDa tryptic fragment
overlap in the linear map and both contain S161, S163,
and S165.
Because chymotrypsin digestion of labeled rVP1 pro-
duced a peptide too small to be analyzed in tricine gels weFig. 3. Mapping the site of guanylylation of rVP1 by chemical and proteolytic clea
locations of the 51 serine residues are indicated by vertical lines as well as the three
the cysteine residues gives rise to nine possible polypeptides of different masse
products by 10% SDS-PAGE and autoradiography together with a marker ladder. (
and the linear map of the 26 kDa NCS fragment is shown below with the position o
(lanes 1–4) and after (lanes 5–8) NCS cleavage, by 10% SDS-PAGE and autor
NTCB fragment used. The position of labeled uncleaved rVP1 is shown on the le
fragment with the V8 cleavage sites indicated by arrowheads; the large 4.2-kDa fra
digestion by 16% SDS-tricine gel electrophoresis and autoradiography. Size marke
NCS fragment with the trypsin cleavage sites indicated by arrowheads; the numb
map of the 26-kDa NCS fragment with the chymotrypsin cleavage sites indicatedhave switched to 40% alkaline PAGE analysis. Digestion of
labeled rVP1 with the three enzymes individually produced
three different-sized labeled peptides, the chymotryptic
peptide being the smallest (Fig. 4). The V8 peptide could
be cleaved by trypsin and chymotrypsin but the tryptic
peptide could only be cleaved by chymotrypsin. The
chymotryptic peptide was resistant to both trypsin and V8
(not shown). These results can be obtained only if the
labeled serine is located on tryptic peptide No. 18 (Table
1). This peptide is cleaved by chymotrypsin to yield a
labeled peptide 160GSGSY164; therefore, the labeled serine
is either S161 or S163. Identical size fragmentation pattern
was observed when labeled virion VP1 was subjected to
the above chemical and enzymatic cleavages (data not
shown).
Guanylylation of mutant rVP1 polypeptides
A number of mutants were constructed within the first
300 residues of rVP1 where in each case a serine was
changed to alanine (see Fig. 3B). All mutations were
confirmed by DNA sequencing. The in vitro guanylylation
reaction of some of these mutants is shown in Fig. 5.
Mutants S2A and S44A were constructed because amino
acid sequence alignment of the three birnavirus VP1 poly-
peptides indicated that S2 was conserved in all threevage. (A) NTCB cleavage. A linear diagram of rVP1 (845 amino acids); the
cysteine residues: C299, C410, and C457. Partial and complete cleavage at
s ranging from 5.3 to 61 kDa. (AA) Analysis of labeled NTCB cleavage
B) Linear diagram of rVP1; tryptophan residues are indicated by arrowheads
f serine residues. (BB) Analysis of labeled NTCB cleavage products, before
adiography. The numbers above each lane indicate the mass in kDa of the
ft; size markers (in kDa) on the right. (C) Linear map of the 26-kDa NCS
gment is shown in bold. (CC) Analysis of labeled rVP1 after V8 and trypsin
rs M (in kilodaltons) are indicated on the left. (D) Linear map of the 26-kDa
ers refer to serine-containing tryptic peptides (listed in Table 1). (E) Linear
by arrowheads. The labeled peptides in D and E are shown in bold.
Table 1
Serine-containing tryptic peptides of rVP1 between residues 1 and 254
No.a Peptide Chymo. V8
1 1MSDIFNSPQNK11 + +
2 12ASILTALMK20  
3 21STTGDVEDVLIPK33  +
6 40DPLDSPQAAAQFKL53 + +
14 91DTVSVPEGTTAFYPK105 + +
18 152EAIATLQYGSGSYSGQLNR170 + 
26 219WAPSWLYNYTGDLSTDK235 + +
27 236SYLPHVTIK244 + 
28 245SSAGLPYIGK254 + 
a Of the first 28 tryptic peptides, only the 9 listed contain serine. Chymo +/
: cleaved or not cleaved by chymotrypsin; V8 +/; cleaved or not cleaved
by V8 (under conditions that cleave at both E and D).
Fig. 5. Effects of serine to alanine mutations in the rVP1 on the in vitro
priming reaction. (A) SDS-PAGE followed by Western blotting and (B)
autoradiography. (C) Amino acid sequence comparison of the three genera of
birnaviruses corresponding to the VP1 160GSGSY164 chymotryptic peptide
of IPNV. Arrows indicate the site of chymotrypsin cleavage. Sequences were
aligned using CLUSTALW (as described by Shwed et al., 2002).
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close in alignment to Y46 of DXV. Site-specific mutants
S7A, S13A, and S94A were also made. All of these
mutants were active in the in vitro guanylylation reaction
(data not shown). Tryptic peptide No. 18 (Table 1) contains
three serine residues, S161, S163, and S165; the first two
are present in the chymotryptic digest between residues 160
and 164. The mutants S161A and S165A were active in the
guanylylation reaction, whereas S163A was inactive. A
triple mutant S161A, S163A, S165A as expected, was also
inactive (data not shown). Mutant S222A was constructed
because S222 is present in both IPNV and IBDV, and in
sequence alignment, it is only a few residues from a
tyrosine residue of DXV. Although serines 245 and 245
are located downstream of the NCS cleavage site, they
were also mutated because their tryptic peptide (similar to
tryptic peptide No.18) is also cleavable by chymotrypsin
but not by V8. Furthermore, S245 and S246 are also
present in VP1 of IBDV. As shown in Fig. 5, the S222A,
S245A, and S246A mutants were all active in the guany-
lylation reaction. One additional mutant, S298A, was also
active in guanylylation (data not shown). Replacing S163
with threonine resulted in labeled phospho-threonine;
whereas replacing S163 with tyrosine yielded a rVP1 that
could not be guanylylated in vitro (data not shown); the
reason for this is not known and it was not pursued any
further. We conclude from these experiments that guanyly-
lation occurs at serine 163.
Based on the sequence alignment between residues
159–164 of IPNV and IBDV (Fig. 5C), we expected S161
to be guanylylated; however, our mutagenesis experiments
indicated that the site of linkage is S163. At this position,
IBDV contains a threonine residue. To verify our results, the
following experiments were performed: (i) phospho-amino
acid determination of labeled VP1 of IBDV; again, phos-
phoserine was indicated (data not shown); (ii) recombinant
baculovirus S163A was pelleted from infected insect tissue
culture medium, the DNA extracted, and the region between
nt 151 and 779 amplified by PCR and the gel-purified 664-
bp fragment re-sequenced in both directions (data not
shown). The results confirmed that, amino acid sequencenon-alignment notwithstanding, the guanylylated residue is
S163.
In vitro RNA synthesis using rVP1 and segment A plus sense
ssRNA as template
Purified rVP1 (expressed either in E. coli or SF cells)
was used as primase-polymerase in a reaction mixture
primed by +ssRNA (segment A). This template was pro-
duced in vitro from the recombinant plasmid (V2.0SegA)
under the T7 promoter. SmaI digestion of the plasmid
followed by run-off transcription produced plus RNA
strands with exact authentic 5V and 3V ends. The RNA
polymerase reaction was monitored by the incorporation
of [a32P]GTP (or [a32P] UTP) followed by 3–10% gradi-
ent SDS-PAGE and autoradiography. In this gradient gel,
both VP1 and dsRNA could be detected by allowing the
dye-front to run out and stopping electrophoresis when the
two high-molecular weight prestained protein markers
(bracketing VP1) reached the bottom of the gel. The data
in Fig. 6 show that within 15 min E. coli rVP1 was
guanylylated (lane 2). Addition of NTPs and RNA template
to the reaction mixture followed by incubation up to 4 h (by
which time the labeled VP1 had disappeared from the
bottom of the gel) resulted in a labeled product that co-
migrated with the dsRNA marker (lanes 3 and 4). Wild-
type rVP1 purified from SF cells gave similar results (lanes
Fig. 6. In vitro RNA polymerase assay using rVP1, [a32P]GTP, and synthetic plus sense RNA strand (segment A) as template as described under Materials and
methods. The products were analyzed by 3–10% gradient SDS-PAGE and autoradiography. Lane 1, Marker (M, viral dsRNA and labeled VP1 indicated on the
left); lane 2, 15-min pulse; lane 3, labeling for 2 h; lane 4, labeling for 4 h using E. coli-expressed rVP1. Lanes 5–11 represent RdRp reaction products using
SF cell-expressed rVP1; lanes 5 and 6 represent 2 and 4 h labeling, respectively; lane 7, labeling for 4 h with [a32P]UTP; lanes 8 and 9, labeling for 2 and 4 h,
respectively, using mutant S161A and [a32P]GTP; lane 10, same as lane 9 after RNase V1 digestion; lane 11, 2-h reaction using the S163A mutant of rVP1.
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the labeled reaction product was digested by RNase V1
(which degrades dsRNA), the labeled rVP1 was recovered
(lane 10). Neither guanylylation nor RNA synthesis was
detected if the wild-type rVP1 was replaced by the mutant
S163A (lane 11). These results show that VP1 is indeed the
RdRp of IPNV, thus the word ‘‘putative’’ henceforth may
be omitted.
To demonstrate that the dsRNA does not represent a
hairpin structure, half of the labeled RNA was extracted
from the reaction product and denatured by boiling and
quickly quenched in ice. Both the native and the denatured
RNA were analyzed by agarose gel electrophoresis, ethi-
dium bromide staining, and autoradiography. Virion dsRNA
served as control. The results shown in Fig. 7 indicate that
the denatured labeled RNA migrated faster than the native
RNA (behaving similar to denatured virion dsRNA), dem-Fig. 7. Agarose gel electrophoresis of native and denatured RNA. Ethidium
bromide-stained RNA extracted from purified virus before (lane 1) and after
heat denaturation (lane 2); polymerase reaction product before (lane 3) and
after denaturation (lane 4). Lanes 5 and 6 represent autoradiograms of lanes
3 and 4.onstrating that the dsRNA synthesis was not initiated by
self-priming.Discussion
In this report, we have established that IPNV RdRp
requires a specific serine residue in its amino-terminal
domain to prime viral RNA synthesis. In all known instan-
ces in which protein acts as a primer for viral RNA
synthesis, the activities required for priming and RNA
polymerization reside on two separate molecules, the VPg
and the RdRp (Salas, 1991); the same is true for DNA
viruses that contain a genome-linked terminal protein (TP)
where the initiation of genome replication requires the
interaction of the TP and the DNA polymerase at the origin
of DNA replication (Salas, 1991). The only exceptions
belong to the members of the Family Hepadnaviridae where
DNA priming (via tyrosine 96 of the P protein) and DNA
polymerase activities reside on the same polypeptide (Weber
et al., 1994; Zoulim and Seeger, 1994). Here we have shown
that in birnaviruses the primer VP1 and the RdRp are also
one and the same molecule.
Our results provide evidence that the cloned, expressed,
and purified rVP1 is capable of self-guanylylation without a
template RNA or other virion polypeptides. Furthermore,
the ability to add the second GMP to produce VP1-pGpG is
an inherent characteristic of the polypeptide. In other animal
viruses (picorna-, adeno-, hepadna-) where nucleic acid
synthesis is protein primed, the reaction (i.e., the nucleoti-
dylation of the TP or VPg) is template dependent where
internal sequences of the viral genome (sometimes in
hairpin structures) serve as templates for the primase reac-
tion (Paul et al., 2000). The only example where the priming
reaction occurs without a template is the uridylylation of
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virus by cloned 3Dpol (Machin et al., 2001).
In all viruses with protein-priming mechanism, the first
nucleotide is linked to a serine or a tyrosine residue (Salas,
1991); so far, threonine-NMP linkage has not been reported.
Here, we have shown that both the IPNV VP1 and the rVP1
are linked to a serine residue and the labeled fragments
produced by chemical or proteolytic cleavage are identical
in the two systems.
Apparently, there is no set rule as to which domain in a
given terminal protein is nucleotidylated. Both in the case of
DHBV polymerase and in IPNV VP1, it is the amino
terminal domain of the polymerase that is nucleotidylated
(tyrosine 96 of the 90-kDa DHBV polymerase vs. serine
163 of the 94-kDa IPNV RdRp). In the 22 amino acid long
poliovirus VPg, the nucleic acid is linked to the 4th amino
acid (tyrosine) (Kitamura et al., 1981). On the other hand, in
the 266 residue long phage B29 TP, the nucleotide linkage is
at the carboxy end at serine 232; similarly, phage PRD1 TP
consists of 259 residues with the linkage at tyrosine 226;
furthermore, in the 80-kDa pTP of adenovirus, the nucleo-
tide linkage is at serine 580 (Salas, 1991).
Analysis of the chemical and proteolytic cleavage prod-
ucts of the labeled VP1 allowed us to map the nucleotide
linkage to the chymotryptic fragment 160GSGSY164. Finally,
with the aid of site-specific mutants, S163 was shown to be
required for amino acid-nucleotide linkage (Fig. 5).
Using the sequence alignments of VP1 of IPNV, IBDV,
and DXV, we were looking for a serine, serine, tyrosine
alignment in the three viruses because DXV VP1 is guany-
lylated at a tyrosine residue (Shwed et al., 2002). No such
alignment was found. It should be noted that the size and
sequences of the polypeptides of IPNV and IBDV are more
closely related than that of DXV. For example, both the
length of the two genome segments and the corresponding
VP1 polypeptides of DXV are larger (977 aa) than the other
two birnaviruses (845 and 878 aa, respectively). It is
therefore possible that the extensive sequence divergence
of the DXV VP1 protein may contribute to altered protein
folding resulting in the localization of the tyrosine residue in
a similar position as the serine residue of IPNVand IBDV in
the tertiary structure of VP1.
The data presented in Fig. 6 show that rVP1 is the primer
and also the RdRp, and at the end of the reaction it remains
covalently bound to the end of the newly synthesized RNA
strand and can be recovered from it by digesting the dsRNA
with RNase V1. It has been reported that the plus strands of
both IPNV and IBDV genome segments can form hairpin
structures at their 3V ends (Boot et al., 1999); therefore, it
was important to determine if in vitro RNA synthesis was
initiated de novo or by a ‘‘copy-back’’ mechanism at the
template 3V end as was shown in the case of rabbit hemor-
rhagic disease virus (Va´squez et al., 2001). The dsRNA
generated by ‘‘copy-back’’ mechanism would be a hairpin-
like structure which would ‘‘open-up’’ during boiling but
would quickly reform the ‘‘hairpin’’ during quenching, thusits migration pattern in agarose gels would be identical to
the undenatured sample. The data in Fig. 7 show that the
denatured reaction product migrated faster as genome-
length single-stranded RNA (like the denatured virion
dsRNA), indicating that it was not the result of copy-back
initiation at the 3Vend of the template RNA. When serine
163 was mutated to alanine, priming by self-guanylylation
did not take place and RNA synthesis was aborted even
though other regions of the VP1, for example, the polymer-
ase motifs, have not been changed.
Although a detailed analysis of the mechanism and
various parameters of in vitro RNA synthesis by the IPNV
RdRp is not the subject of this communication, nevertheless
several conclusions can be summarized. (i) As in the case of
B6 phage RdRp (Makeyev and Bamford, 2000b), only a
single round of RNA synthesis takes place when using
rVP1; reinitiation is not observed. (ii) Like the B6 RdRp,
the rVP1 of IPNV also synthesizes a minus strand on a
synthetically derived plus-strand (replication); however, in
this case, rVP1 acts both as primer and polymerase, and at
the end of the reaction remains covalently linked to the 5V
end of the product strand, thereby becoming a genome-
linked protein or VPg. In this respect, it behaves like the
polymerase of HBV which also acts as a primer and at the
end of minus DNA strand synthesis becomes a covalently
linked terminal protein (TP) (Zoulim and Seeger, 1994).
We are presently studying the specificity of the RdRp as
well as to identify its catalytic domain(s). We wish to
determine whether IPNV RdRp functions as a dimer (where
one molecule primes and the other polymerizes) or as a
monomer (where one molecule carries out both functions).
HIV reverse transcriptase functions as a heterodimer (Hos-
tomsky et al., 1992); the DHBV polymerase functions as a
monomer (Zoulim and Seeger, 1994). In the case of IPNV,
this could be determined by assaying two variants of this
enzyme together, with mutations at the site of priming for
RNA synthesis (S163) and at the catalytic domain for their
potential to complement each other. Complementation
would indicate that RdRp functions as a dimer; lack of
complementation would indicate that it functions as a
monomer.Materials and methods
Cells and viruses
IPNV (Jasper) was grown at 20 jC in CHSE cell
monolayers and purified by sucrose and cesium chloride
gradient centrifugation as described previously (Dobos and
Rowe, 1977). The final purified virus band from CsCl
gradients was dialyzed against 10 mM Tris–HCl pH 8.0
and stored in aliquots at 20 jC at a concentration of
approximately 1 mg/ml. Insect Sf21 cells were grown at 28
jC as monolayers in Grace’s insect medium (Gibco BRL)
supplemented with 10% fetal calf serum (FCS). For protein
H.-T. Xu et al. / Virology 3expression, approximately 70% confluent monolayers were
infected with recombinant baculovirus at a multiplicity of
infection of about 10 and the cell cultures were incubated at
20 jC for 4 days.
Transcription plasmids
The V2.0 plasmid containing the T7 promoter, hepatitis
delta virus ribozyme, and the T7 terminator was the generous
gift of A.K. Pattnaik (Pattnaik et al., 1992). The IPNV
segment A cDNA was amplified by PCR using pTZSegA
as template (GenBank accession NC 001915). Primers A5 5V-
AAAGAGAGTTTCAACGTTA-3V and A3 5VGGGGCCC-
CCTGGGGGGCCGGGGTTA-3V were used in the PCR
reaction after the two 5V terminal nucleotides ’’GG’’ of
Segment A were eliminated. The product was gel purified
and cloned into the StuI and SmaI sites of the V2.0 transcrip-
tion vector to produce V2.0SegA. The insert was sequenced
completely to preclude cloning errors and digested with SmaI
to linearize the plasmid. RNA run-off transcripts were syn-
thesized using the Riboprobe in vitro transcription system
(Promega).
To construct the V2.0 SegB transcription vector, the
SegB cDNA sequence was amplified by PCR using the
pTZ SegB as template (GenBank accession no. M58756)
and the first two nucleotides of SegB were eliminated.
DeepVent DNA polymerase (New England Biolabs) was
used to amplify SegB by PCR using primers B5 5V-AAA-
CAGTGGGTCAACGTTGGTGGCA-3Vand B3 5V-GGGG-
TCCCTGGCGGAACCGGATG-3V. The product was gel
purified and cloned into the StuI and SmaI sites of V2.0
vector to produce V2.0SegB.
Plasmid construction for baculovirus expression of rVP1
The transfer vector pFastBacDUAL (Gibco BRL) was
used to engineer the recombinant donor plasmid as follows:
(i) a 165-bp fragment containing the his6 coding sequence
was amplified by PCR from pET21a(+) vector DNA
(Novagen) using primers pETHis5NotI 5V-TCGAGCTCC-
GTCGACAAGC-3V and pETHis3XbaI 5V-gctctaga TCA-
AGACCCGTTTA-3V (underlined indicate engineered
restriction site); (ii) after digestion of this fragment with
NotI and XbaI, the resulting 135-bp fragment was gel-
purified and cloned into the NotI and XbaI sites of pFast-
BacDUAL DNA producing pDUAL/C-His; (iii) the VP1
coding sequence of recombinant plasmid V2.0SegB was
amplified by PCR using primers B5BamHI 5V-cgggatcc-
ATGTCGGACATCTTCAAC-3V and B3EagI 5V-gccggccg -
aCTGGTTTCTTCTCTGCTT-3V; (iv) after digesting this
PCR fragment with BamHI and EagI, it was cloned into
the BamHI and NotI sites of pDUAL/C-His generating the
recombinant donor plasmid pDUAL/RVP1 which in the
Bac-to-Bac expression system directed the synthesis of
full-length wild-type VP1 fused at the carboxy end with
the -SAALEH6 tag.Plasmid construction for rVP1 expression in E. coli
Plasmid V2.0SegB containing the full-length cDNA
IPNV genome segment B was used as template. The DNA
fragment encoding VP1 was amplified by PCR using Deep-
VentR DNA Polymerase (New England Biolabs) and pri-
mers B5NdeI, 5V-gctcatATGTCGGACATCTTCAAC-3V and
B3SalI, 5V-gcgtcgac CTGGTTTCTCTGCTT-3V. The stop
codon was deleted to produce C-terminal fusion protein.
The PCR fragment was digested with NdeI and SalI (under-
lined sites in the primer sequences) ligated with the large
fragment of the NdeI–XhoI cut vector pET21a(+) (Nova-
gen). E. coli BL21(DE3) (Novagen) was transformed with
the resultant plasmid pETRVP1 to give the rVP1-producing
strain BL21(DE3/RVP1) which can express wild-type VP1
fused at the carboxy end with the -VEH6 tag.
Site-directed mutagenesis
All target serine residues were mutated to alanine using
the Quick-change mutagenesis kit (Stratagene). A 315-bp
fragment encompassing the BamHI and AlfII sites of
pDUAL/RVP1 was amplified by PCR using primers
PdualVP1 BamHI-f 5V-ACCGTCCCACCATCGGGC-3V
and pDualVP1AflII-r 5V-CTGGGACGCTTACCGTGTC-3V,
cloned into pCR-Blunt DNA (Invitrogen), and used for
generation of serine-to-alanine mutation of VP1 at positions
2, 7, 13, and 44. Similarly, a 757-bp fragment encompassing
the AflII and BssHII sites of pDUAL/RVP1 was amplified by
PCR using primers pDualVP1AflII-f 5V-TGGAAGACGG-
CAAGC-3V and pDualVP1BssHII-r 5V-GACACCATTGA-
TAGTAG-3V, cloned into pCR-Blunt DNA, and used for
generation of serine-to-alanine mutations of VP1 at positions
94, 161, 163, 165, 222, 245, 246, and 298. All mutations
were confirmed by DNA sequencing. The 270-bp BamHI–
AlfII fragment or the 703-bp AlfII–BssHII fragment contain-
ing the desired mutations was subcloned into pDUAL/RVP1
to replace the corresponding wild-type fragments.
Generation of recombinant baculoviruses
The Bac-to-Bac baculovirus expression system (Gibco
BRL) was used to generate recombinant baculovirus accord-
ing to the manufacturers’ specifications. Insect cells were
grown at 28 jC for 5 days, and using part of the culture
medium the recombinant baculovirus was amplified in Sf21
cells.
In vitro guanylylation of VP1
A 30-Al reaction mixture in 10 mM Tris–HCl pH 8.0
contained 5–10 Ag of purified virus, 0.5 mM MgCl2, and 20
ACi [a32P] GTP (specific activity 3000 Ci/mmol, ICN).
After incubation in a 37 jC water bath for 15 min, the
reaction was stopped by the addition of an equal volume of
double concentration electrophoresis sample buffer (ESB;
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10% glycerol, and a trace of bromphenol blue) followed by
immersion in a boiling water bath for 5 min. Purified rVP1
was similarly labeled except that 0.5 mM MnCl2 was used.
Polyacrylamide gel electrophoresis, Western blot analysis,
and autoradiography
To analyze protein products, the discontinuous 10%
SDS-PAGE system developed by Laemmli (1970) was used.
Prestained marker kit was purchased from Fermentas and
Benchmark Protein marker ladder from Gibco BRL. The
gels were stained with Coomassie brilliant blue in acetic
acid/methanol/water (5:40:55 vol/vol), destained, dried un-
der vacuum, and subjected to autoradiography using Kodak
X-OMAT AR X-ray film. Small proteins were analyzed in
16.5% SDS-Tricine gels (Sha¨gger and von Jagow, 1987)
using Bio-Rad Rainbow Low Mwt prestained markers. For
Western blotting, the proteins were electrotransferred to
PVDF membrane (Immobilon, Millipore), blocked with
5% skimmed milk in TBS Tween (1%), and using the same
buffer were incubated with anti IPNV rabbit serum (1: 500
dilution) for 1 h, washed with TBS Tween, and incubated
with alkaline phosphatase-conjugated goat anti-rabbit IgG
for 1 h. The membrane was extensively washed and
developed with NBT/BCIP according to the manufacturer’s
specifications (Bio-Rad). Fractionation of small tryptic and
chymotryptic peptides used alkaline PAGE (West et al.,
1984).
Purification of rVP1 from insect cells and from E. coli
Recombinant baculovirus-infected cells were scraped off
the tissue culture flask 4 days after infection. The cells were
pelleted, washed with PBS, re-pelleted, and either processed
immediately or stored as frozen pellets at 20 jC until
needed. The rVP1 was purified using the batch method of
Ni-NTA metal-affinity chromatography of QIAexpressionist
(QIAGEN Inc.) under native conditions according to the
manufacturer specifications. All buffers contained a cocktail
of protease inhibitors (Complete, Roche) and the eluted
protein was dialyzed against Storage Buffer (10 mM Tris–
HCl pH 8.0, 10 mM NaCl, 20% glycerol). When required,
the protein was concentrated by using a Centricon Plus 20
centrifugal filter. Six 150 cm2 tissue culture flasks yielded 1
ml of packed cells, from which 1.5 mg of rVP1 could be
purified. This preparation was 75–85% pure based on SDS-
PAGE and Coomassie blue staining.
rVP1 was expressed in E. coli by growing the rVP1
producing strain BL21(DE3/VP1) in LB broth containing
150 Ag ampicillin/ml to an optical density of 0.5–0.6 at
OD600 at 37 jC. Protein expression was induced at 18 jC
for 48 h by addition of 1 mM IPTG. The cells were collected
by centrifugation, washed once with cold PBS and once in
Tris–HCl pH 8.0, and disrupted using a French pressure
cell. The lysate was centrifuged at 10000 rpm for 30 minand the supernatant at 30000  g for 60 min. The pellet was
discarded and the supernatant was processed for Ni-NTA
chromatography under native conditions according to the
manufacturer’s specification. Storage conditions were as for
rVP1 expressed in recombinant baculovirus-infected cells.
Typically, a 2-l culture yielded 12 ml of packed cells.
Approximately 2.2 mg of rVP1 (90–95% pure) could be
purified from 1 ml of packed cells.
Phosphoamino acid analysis
The [32P]-labeled virion VP1 and rVP1 was analyzed by
SDS-PAGE, electrophoretically transferred to a PDVF
membrane (Immobilon; Millipore), and detected by autora-
diography. The piece of Immobilon membrane containing
the labeled protein was wetted briefly in methanol, rinsed in
water and cut to small pieces, and placed in a microcen-
trifuge tube containing 0.5 ml of 6 N HCl; the tube was
tightly capped and the protein was hydrolyzed at 110 jC for
1 h. After hydrolysis, the preparation was centrifuged, the
supernatant was transferred to a new tube and lyophilized.
The dried sample was resuspended in 10 Al of water and
spotted onto thin layer cellulose plates together with phos-
phoamino acid markers and subjected to thin layer electro-
phoresis in 0.5% pyridine–5% acetic acid (pH 3.5) at 400 V
for 100 min. The phosphoamino acid standards were located
by spraying the plate with a 0.1% solution of ninhydrin in
ethanol followed by heating in an oven at 60 jC. Autora-
diography was with Kodak XAR-5 film at 80 jC using an
intensifying screen.
PEI chromatography
After SDS-PAGE, the labeled VP1 was electrophoreti-
cally transferred to a PDVF membrane and located by
autoradiography. Using the autoradiogram as a guide, the
labeled VP1 was cut out of the membrane, rinsed in
methanol, and re-wetted by placing it in 0.5% PVP-360
(polyvinylpyrolidone) in 100 mM acetic acid for 30 min at
37 jC. The membrane was then cut to small pieces, placed
in a microcentrifuge tube, and washed extensively with
water followed by three rinses in 50 mM NH4HCO3.
Enough of the latter solution was added to cover the
membrane bits (approximately 400 Al) and incubated with
12 Ag sequencing grade trypsin (Roche) for 6 h at 37 jC. At
the end of the digestion, the membrane fragments were
discarded, the sample was centrifuged briefly, the superna-
tant transferred to a fresh microfuge tube, and the prepara-
tion was lyophilized. The labeled peptides were resuspended
in 20 Al of water and 5-Al aliquots were incubated with an
equal volume of 1 M piperidine for alkaline hydrolysis at 37
jC for 1 h. The treated material was spotted on a poly-
ethylenimine (PEI) cellulose thin layer plate, developed in
0.75 M KH2PO4, and analyzed by autoradiography. Partially
hydrolyzed [a32P]GTP was included to serve as GTP, GDP,
and GMP markers.
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Cleavage of VP1 at cysteinyl residues utilized 2-Nitro-5-
thiocyanatobenzoic acid (NTCB, Fluka) as described by Lu
and Gracy (1981). Briefly, the radiolabeled VP1 bands were
sliced out of the dried polyacrylamide gels (0.75-mm-thick
gels) and each slice was rehydrated at 37 jC for 1 h in 100
Al 8 M urea in 200 mM Tris–HCl pH 8.0 to which 2 Al 50
mM DTTwas added. Ten microliters NTCB (50 mM in 100
mM Tris–HCl pH 8.0) was added followed by 10 Al of 0.1
M Tris base (to ensure alkalinity) and the gel slices
incubated at 37 jC for 30 min. Each was washed exten-
sively with 8 M urea in 150 mM Tris–HCl pH 8.9 and left
in the same solution (in just enough volume to cover the gel
slice) at 37 jC for 16 h, after which gel slices were stuffed
to the bottom of the wells of a 1 mm thick 10% SDS-
polyacrylamide gel and subjected to electrophoresis fol-
lowed by autoradiography.
Cleavage of VP1 at tryptophan residues was achieved in
gel slices using N-chlorosuccinimide (NCS) as described by
Lischwe and Sung (1977). The dried gel slices containing
labeled VP1 were re-hydrated and extensively washed in
urea/acetic acid/water (1 g of urea, 1 ml of acetic acid plus
water to 10 ml). Standard cleavage conditions were in the
same solution containing 20 mM NCS at room temperature
for 30 min. The gel slices were washed with water followed
by equilibration in 10% glycerol, 15% beta-mercaptoetha-
nol, 3% SDS, and 0.0625 M Tris–HCl, pH 6.8 (10 ml) for
90 min with three changes and stuffed to the bottom of the
wells of a 1 mm thick 10% SDS polyacrylamides gel
followed by electrophoresis and autoradiography.
Enzymatic cleavage of VP1
V8 protease, trypsin, and chymotrypsin cleavage of VP1
blotted onto PDVF membranes was achieved as described
above (under PEI chromatography). Phosphate buffer (50
mM) pH 7.8 was used for V8 digestion to ensure that
cleavage occurred at the carboxy side of both Glu and Asp.
In case of sequential double digestion, for example, V8
followed by trypsin or chymotrypsin, the labeled V8 digest
was analyzed in 40% alkaline polyacrylamide gels and the
labeled peptide located in the dried gel by autoradiography.
The peptide was sliced out of the gel, rehydrated, and briefly
washed in 50 mM NH4HCO3 pH 8.0 (long enough to wash
out the Tris but not the labeled peptide); enough ammonium
carbonate was added to cover the gel pieces followed by 10
Ag trypsin (or chymotrypsin) and incubated in a 37 jC water
bath overnight. The liquid was removed, clarified by cen-
trifugation, and lyophilized.
In vitro RNA synthesis
RdRp assays were done essentially as described for
hepatitis C virus by Lohmann et al. (1997). Briefly, a 30-
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Tris–HCl pH 8.0, 1 mM MnCl2, 5 mM MgCl2, 1 mM DTT,
1 mM EDTA, 40 U RNasin (Promega), 10 ACi of [a32P]
UTP or GTP (3000 Ci/mmol; ICN) adjusted to 10 AM with
nonradioactive UTP or GTP, and 500 AM each of the three
nonradioactive NTPs, 0.5 Ag of SegA pus RNA, and 5–10
Ag of rVP1. The reaction mixture was incubated at 37 jC
and aliquots were removed at intervals and mixed with
5XESB. The reaction products were analyzed by 3–10%
SDS-PAGE where the two largest prestained protein size
markers (bracketing VP1) were allowed to migrate to the
bottom of the gel. This way VP1, ssRNA, and dsRNA could
be resolved in the same gel which was dried and placed on
X-ray film for autoradiography.
Agarose gel electrophoresis
Both the labeled polymerase reaction product and puri-
fied virus were separately digested by proteinase K (1 mg/
ml) in the presence of 1% SDS and the RNA extracted by
phenol-chloroform followed by ethanol precipitation at 20
jC. Each of the washed precipitates was resuspended in
sterile distilled water and half of each was heated in a
boiling water bath (3 min) then quickly cooled in wet-ice.
Both the heat-denatured and the unheated samples were
analyzed by 1% agarose gel electrophoresis, ethidium bro-
mide staining, and autoradiography.Acknowledgments
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